5-MeO-DsBT

5-MeO-DsBT
Clinical data
Other names5-MeO-DSBT; 5-Methoxy-N,N-di-sec-butyltryptamine
ATC code
  • None
Identifiers
  • N-butan-2-yl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]butan-2-amine
PubChem CID
Chemical and physical data
FormulaC19H30N2O
Molar mass302.462 g·mol−1
3D model (JSmol)
  • CCC(C)N(CCC1=CNC2=C1C=C(C=C2)OC)C(C)CC
  • InChI=1S/C19H30N2O/c1-6-14(3)21(15(4)7-2)11-10-16-13-20-19-9-8-17(22-5)12-18(16)19/h8-9,12-15,20H,6-7,10-11H2,1-5H3
  • Key:KJOIPZZWWSZLRE-UHFFFAOYSA-N

5-MeO-DsBT, also known as 5-methoxy-N,N-di-sec-butyltryptamine, is a chemical compound and possible psychedelic drug of the tryptamine and 5-methoxytryptamine families related to 5-MeO-DMT.[1] It was briefly mentioned by Alexander Shulgin in his 1997 book TiHKAL (Tryptamines I Have Known and Loved).[1] He described it as being an unknown compound.[1] Relatedly, its route, dose, and duration were not described.[1] 5-MeO-DsBT was first described in the literature by Shulgin in TiHKAL in 1997.[1] It is a skeletal isomer of 5-MeO-DBT.[1] Subsequently, close analogues of 5-MeO-DsBT like 5-MeO-MsBT and 5-MeO-NsBT emerged as novel designer drugs in the early 2020s.[2][3][4] 5-MeO-DsBT is not a controlled substance in Canada as of 2025.[5]

See also

References

  1. ^ a b c d e f Shulgin, Alexander; Shulgin, Ann (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. ISBN 0-9630096-9-9. OCLC 38503252.
  2. ^ "5-MeO-MsBT (5-methoxy-N-methyl-N-secbutyltryptamine)". AIPSIN (in Russian). Retrieved 2 January 2026.
  3. ^ "5-MeO-NsBT (5-MeO-N-secbutyltryptamine)". АИПСИН (in Russian). Retrieved 6 January 2026.
  4. ^ Yurchenko R, Yurchenko L, Pavlovets Y, Galetskaya I (January 2023). "Recent trends in the identification of psychoactive substances". AIPSIN Belarusian Monitoring Platform (in Russian) (37). doi:10.13140/RG.2.2.34396.46722. Retrieved 2 January 2026.
  5. ^ "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.